Explaining Medicine
  • News
  • Health & Lifestyle
    • Diet & Weight Management
    • Exercise & Fitness
    • Nutrition, Food & Recipes
    • Prevention & Wellness
  • Conditions
    • Custom1
      • Conditions A-Z
      • Procedures A-Z
      • Allergies
      • Alzheimer’s
      • Arthritis
      • Asthma
      • Blood Pressure
      • Cholesterol
      • Cancer
    • Custom2
      • Chronic Pain
      • Cold Flu
      • Depression
      • Diabetes
      • Digestion
      • Eyesight
      • Health Living
      • Healthy Kids
      • Hearing Ear
    • Custom3
      • Heart
      • HIV/AIDS
      • Infectious Disease
      • Lung Conditions
      • Menopause
      • Men’s Health
      • Mental Health
      • Migraine
      • Neurology
    • Custom4
      • Oral Health
      • Pregnancy
      • Senior Health
      • Sexual Health
      • Skin Problems
      • Sleep
      • Thyroid
      • Travel Health
      • Women’s Health
  • Medications
    • Medications
    • Supplements and Vitamins
  • Medical Dictionary
  • Health Alerts
After cancer diagnosis, a neurosurgeon sees life, death...
Wegovy works. But here’s what happens if you...
A baby spent 36 days at an in-network...
Multiple Myeloma: How Do Disparities Affect Outcomes?
Can you bond without the ‘love hormone’? These...
FDA moves to ease restrictions on blood donations...
When gun violence ends young lives, these men...
When is it OK to make germs worse...
An FDA committee votes to roll out a...
Your kids are adorable germ vectors. Here’s how...
Top Posts

Explaining Medicine

  • News
  • Health & Lifestyle
    • Diet & Weight Management
    • Exercise & Fitness
    • Nutrition, Food & Recipes
    • Prevention & Wellness
  • Conditions
    • Custom1
      • Conditions A-Z
      • Procedures A-Z
      • Allergies
      • Alzheimer’s
      • Arthritis
      • Asthma
      • Blood Pressure
      • Cholesterol
      • Cancer
    • Custom2
      • Chronic Pain
      • Cold Flu
      • Depression
      • Diabetes
      • Digestion
      • Eyesight
      • Health Living
      • Healthy Kids
      • Hearing Ear
    • Custom3
      • Heart
      • HIV/AIDS
      • Infectious Disease
      • Lung Conditions
      • Menopause
      • Men’s Health
      • Mental Health
      • Migraine
      • Neurology
    • Custom4
      • Oral Health
      • Pregnancy
      • Senior Health
      • Sexual Health
      • Skin Problems
      • Sleep
      • Thyroid
      • Travel Health
      • Women’s Health
  • Medications
    • Medications
    • Supplements and Vitamins
  • Medical Dictionary
  • Health Alerts
  • News

    Blame Game on Insulin Costs Leaves Patients Behind

    by WebMD April 11, 2019
    By Rachel Bluth, Kaiser Health News

    A casual observer of Wednesday’s House Energy and Commerce subcommittee hearing might think insulin prices just go up by themselves.

    After all, the key industry executives filed opening statements to the congressional panel outlining patient-assistance programs, coupons and discounts — a range of price reductions that might make one think this life-or-death diabetes medication is easily affordable to the patients who need it.

    In fact, the price of insulin nearly doubled from 2012 to 2016 alone, triggering national headlines about the resulting hardships — sometimes deadly — suffered by people with the Type I-version of the condition who are left to ration insulin because it is too expensive for them to use as prescribed.

    The three drug manufacturers that make insulin — Eli Lilly, Novo Nordisk and Sanofi — joined three pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRx — to testify before the Oversight and Investigations panel at its second hearing probing the corporate maneuvers behind the skyrocketing costs.

    Pharmacy benefit managers, or PBMs, are the go-between companies that negotiate with drugmakers on which medicines will make insurance plans’ lists of covered drugs and how much insurers’ plans will pay for them.

    The subcommittee members came looking for a fight. The often-contentious hearing featured Republicans and Democrats alike hammering the witnesses about prices, repeatedly asking questions: Why not just lower the list price? Do you really think the market is working? How do you sleep at night?

    “I want to congratulate all of you today for accomplishing something we’ve been trying to do in Congress, and that is to create bipartisanship,” said Rep. Buddy Carter (R-Ga.), who isn’t even on the committee but came to ask questions, anyway. “This is going to end. I have witnessed it. I have seen what you’ve done.”

    Chairwoman Diana DeGette (D-Colo.) asked each of the witnesses the direct question: Why were insulin prices rising?

    In response, manufacturers and PBMs pointed fingers at one another while seated at the same witness table.

    The manufacturers cast rebates as the root of the problem. Rebates are discounts paid by a drugmaker to a PBM, and those savings are generally not passed on to the customer at the pharmacy counter.

    Continued

    “Seventy-five percent of our list price is paid in rebates and discounts to secure access,” said Mike Mason, a senior vice president for Eli Lilly.

    But PBM executives had a very different view.

    “I have no idea why the prices are so high, none of it is the fault of rebates,” said Amy Bricker, a senior vice president for Express Scripts.

    Manufacturers painted themselves as victims, saying they were forced to raise their list prices to compensate for the ever-growing rebates demanded by PBMs to keep their insulin on drug formularies (the list of drugs covered under an insurance plan).

    But then PBMs saw things very differently. The real drivers of the sky-rocketing costs are the high list prices set by manufacturers along with the lack of generic alternatives, noted Dr. Sumit Dutta, OptumRx senior vice president and chief medical officer. And the PBMs also claimed to wear the white hat in this battle because without their rebate system prices would go up and no one would be advocating for patients.

    Overall, the subcommittee members seemed exasperated by these circular arguments.

    The response when Eli Lilly’s Mason mentioned his company’s recently introduced lower-priced insulin highlighted this impatience.

    “It took 15 years and global public outcry to do it?” said Rep. Joseph Kennedy (D-Mass.), who was visibly frustrated that none of the drugmakers could explain how prices were set.

    Subcommittee members also pounded the executives on some traditional weak spots, topics such as CEO pay and corporate profits.

    Rep. Raul Ruiz (D-Calif.) asked each witness what they were willing to give up for patients to have access to less expensive drugs. He interrupted each answer, telling them the status quo isn’t good enough.

    “Somebody’s getting richer,” Ruiz said. “Somebody is making money on the backs of our patients.”

    Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

    WebMD News from Kaiser Health News

    ©2013-2018 Henry J. Kaiser Family Foundation. All rights reserved.

    Read the article here

    Share this Post

    Share Explaining Medicine Share Explaining Medicine

    Blame Game on Insulin Costs Leaves Patients Behind was last modified: April 18th, 2019 by WebMD

    Related

    diabetesdrugsinsulininsurance planinsurance planssleep
    0 comment
    0
    Facebook Twitter Google + Pinterest
    WebMD

    previous post
    Measles Outbreak: What You Should Know
    next post
    Ketamine May Relieve Depression By Repairing Damaged Brain Circuits

    Related Articles

    Achieving aequanimitas and physician well-being

    March 12, 2018

    Why Black Americans are more likely to be saddled with medical debt

    October 27, 2022

    Fitting MS Into Your Schedule

    December 12, 2022

    Many Who Buy ACA Health Plans For 2019 Find Lower Prices And More Choice

    November 23, 2018

    Salmonella Fear Spurs Duncan Hines Cake Mix Recall

    November 6, 2018

    To Manage Dementia Well, Start With The Caregivers

    September 15, 2018

    Just One Concussion Could Raise Parkinson’s Risk

    April 18, 2018

    Opioids Given Too Easily to Children, Study Finds

    July 16, 2018

    Motrin vs. Tylenol for children: A pediatrician explains

    March 12, 2019

    Is 100 the New 80? What’s It Take to Live Longer?

    September 20, 2018

    Recent Posts

    • After cancer diagnosis, a neurosurgeon sees life, death and his career in a new way

      January 30, 2023
    • Wegovy works. But here’s what happens if you can’t afford to keep taking the drug

      January 30, 2023
    • A baby spent 36 days at an in-network hospital. Why did her parents get a huge bill?

      January 30, 2023
    • Multiple Myeloma: How Do Disparities Affect Outcomes?

      January 27, 2023
    • Can you bond without the ‘love hormone’? These cuddly rodents show it’s possible

      January 27, 2023

    Keep in touch

    Facebook Twitter Google + RSS

    Recent Posts

    • After cancer diagnosis, a neurosurgeon sees life, death and his career in a new way

      January 30, 2023
    • Wegovy works. But here’s what happens if you can’t afford to keep taking the drug

      January 30, 2023
    • A baby spent 36 days at an in-network hospital. Why did her parents get a huge bill?

      January 30, 2023
    • Multiple Myeloma: How Do Disparities Affect Outcomes?

      January 27, 2023
    • Can you bond without the ‘love hormone’? These cuddly rodents show it’s possible

      January 27, 2023
    • Terms of Service
    • Privacy Policy

    @2023 - Explaining Medicine. All Right Reserved.


    Back To Top
    Explaining Medicine
    Proudly powered by WordPress Theme: soledad child.